Mutations and Polymorphisms in the Genes for Myocilin and Optineurin as the Risk Factors of Primary Open-Angle Glaucoma
- 29 Downloads
A collection of DNA samples obtained from primary open-angle glaucoma (POAG) patients from St. Petersburg was analyzed for single-strand conformation polymorphism (SSCP) to reveal sequence variants in exon 3 of the myocilin gene (MYOC/TIGR) and in exons 4 and 5 of the optineurin gene (OPTN), where most of the mutations revealed worldwide are located. The Q368X mutation (c. 1102 C → T) in exon 3 of MYOC/TIGR was detected in 1.2% (2/170) of the POAG patients from St. Petersburg, i.e., with the frequency close to that observed in other world populations. Three known polymorphisms in exon 3 of MYOC/TIGR were detected in glaucoma patients, namely Y347Y (c. 1041 T → C) (12.4%), T325T (c. 975 G → A) (0.6%), and K398R (c. 1193 A → G) (0.6%). No statistically significant differences in frequencies of these polymorphisms were revealed between the POAG patient and control groups. The L41L polymorphism (c. 433 G → A) in exon 4 of OPTN was detected in 2.9% of probands and in 1% of controls. The frequency of heterozygotes for the M98K polymorphism (c. 603 T → A) in the OPTN exon 5 was statistically significantly higher (P = 0.036; Fisher's exact test) among the POAG patients (6.5%) than among the controls (1%). In the sample examined the E50K (c. 458G → A) mutation, typical of the patients with pseudonormal intraocular pressure glaucoma (commonly known as low-tension glaucoma, LTG) was not found.
KeywordsGlaucoma Sequence Variant Intraocular Pressure World Population Glaucoma Patient
Unable to display preview. Download preview PDF.
- 2.Libman, E.S. and Shakhova, E.V., State and Dynamics of Blindness and Disability Caused by Pathology of the Organ of Vision in Russia, Tezisy dokladov VII s”ezda oftal'mologov Rossii (Proc. VII Meet. of Russian Ophthalmologists), Moscow, 2000, vol. 2, pp. 209–214.Google Scholar
- 4.Nesterov, A.P., Primary Open-Angle Glaucoma: Pathogenesis and Principles of Treatment, Klin. Oftal'mol., 2000, vol. 1, no.1, pp. 4–5.Google Scholar
- 5.Shields, M.B., Textbook of Glaucoma, Baltimore: Williams & Wilkins, 1987.Google Scholar
- 13.Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York: Cold Spring Harbor Lab., 1989.Google Scholar
- 17.Astakhov, Yu.S., Kvasova, M.D., Mandel'shtam, M.Yu., et al., Molecular Genetic Aspects of Primary Open-Angle Glaucoma, Fedorovskie chteniya-2003: Nauchno-prakticheskaya konferentsiya “Sovremennye tekhnologii lecheniya glaukomy” (Moskva, 20–21 iyunya 2003 g.) (Fedorov Course of Lectures-2003: Conf. “Modern Techniques of Treating Glaucoma” (Moscow, June 20–21, 2003), Takhchidi, Kh.P., Ed., Moscow, 2003, pp. 23–25.Google Scholar
- 20.Jana, N.R., Tanaka, M., Wang, G., and Nukina, N., Polyglutamine Length-Dependent Interaction of Hsp40 and Hsp70 Family Chaperones with Truncated N-Terminal Huntingtin: Their Role in Suppression of Aggregation and Cellular Toxicity, Hum. Mol. Genet., 2000, vol. 9, pp. 2009–2018.CrossRefPubMedGoogle Scholar
- 21.Vazquez, C.M., Herrero, O.M., Bastus, B.M., et al., Mutations in the Third Exon of the MYOC Gene in Spanish Patients with Primary Open-Angle Glaucoma, Ophthal. Genet., 2000, vol. 21, pp. 109–115.Google Scholar
- 22.Umeda, T., Matsuo, T., Nagayama, M., et al., Clinical Relevance of Optineurin Sequence Alterations in Japanese Glaucoma Patients, Ophthal. Genet., 2004, vol. 25, no.2, pp. 91–99.Google Scholar
- 25.Sarfarazi, M. and Rezaie, T., Optineurin in Primary Open-Angle Glaucoma, Ophthalmol. Clin. N. Am., 2003, vol. 16, pp. 529–541.Google Scholar